San Diego-based mostly Viking Therapeutics marked itself as a serious competitor inside the weight loss drug market in February following revealing promising information from the mid-phase trial of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when provided being a weekly injection As well as in Ma